Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Free Market Capitalism: Laughably Predictable

On Wednesday, as the kiddies were upset over a swooning S&P, then trading a paltry 5% from the all-time high of 3,027, I tweeted out this graphic that perfectly describes my cynical view of the paper markets around the world. What prompted me to exercise my artis...
Streetwise Reports | October 8, 2019 |

Geothermal energy: These stocks could suddenly double in value

Less than two months ago, Canadian pipeline giant Enbridge did something strange . The company announced it was spending $24 million to take a 20% stake in a modest, 35-megawatt project being developed by a company few investors have ever heard of: U.S. Geothermal ( AMEX:...
Larsen Kusick | October 28, 2012 |

Sangamo and Pfizer Report Positive Results for Hemophilia A Study

Sangamo Therapeutics and partner Pfizer reported positive results for phase 1/2 Alta study for hemophilia A at the International Society on Thrombosis and Hemostasis Congress in Melbourne, Australia. Sangamo Therapeutics Inc. (SGMO:NASDAQ) shares are up...
Streetwise Reports | July 9, 2019 |

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...
Streetwise Reports | June 2, 2020 |

XPhyto: Proof of Concept for Mescalin Synthesis

It’s become a much talked-about story on both sides of the Atlantic. XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTCQB: XPHYF) has earned considerable media coverage in recent months due to its expansion into the development of psychedelic d...
Marc Davis | June 9, 2021 |

No time like the present for Goldshore Resources

Goldshore Resources (GSHR) is a junior gold development company that is tri-listed and is also relatively new. Trading here in Canada the company occupies the Venture Exchange. The company has managed to stay well-financed and is supported by a strong management group. ...
Brieanna McCutcheon | May 31, 2023 |

Will the Transitory Inflation Turn into a Tailwind for Gold?

Chair Powell claims that subdued inflation is caused by transitory factors. Does the recent data confirms his views? And just how transitory is the new tariff rate on $200bn Chinese imports? Will we see a creep higher in inflation about to lift the gold prices? CPI Edges Up...
Arkadiusz Sieron | May 14, 2019 |

Gold and Silver Reversals - Impossible Not to Notice

What a remarkable day Friday has been! Going into the U.S. session open, we have seen gold challenging its early-June highs. The barrage of geopolitical news has been deafening and gold had literally nowhere to go but up. But something “unexpected” y...
Przemyslaw Radomski, CFA | June 18, 2019 |

Can the Oil Bulls Succeed in Their Comeback Attempt After Yesterday’s Slide?

After several days of relative hesitation, oil did finally moved through and closed below an important support level, making our position immediately profitable. Can the bulls however mount a strong enough response to invalidate the breakdown? So far, it doesn’...
Przemyslaw Radomski, CFA | October 1, 2019 |

Aquestive Therapeutics Shares Up on Pipeline Update and Raised Full-Year 2019 Guidance

Aquestive Therapeutics shares traded 20% higher today after the firm reported Q3/19 earnings and raised its FY/19 guidance. The firm states it expects to complete its NDA for Libervant buccal film near the end of this month. Yesterday afternoon, specialty pharmaceutic...
Streetwise Reports | November 7, 2019 |
1 2 3 4 5